baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

JP Morgan Put 190 PGR 15.11.2024/ DE000JK2LK55 /

2024-06-14 10:39:11 AM	Chg.0.000	Bid1:30:50 PM	Ask1:30:50 PM	Underlying	Strike price	Expiration date	Option type
0.910EUR	0.00%	0.930 Bid Size: 2,000	1.000 Ask Size: 2,000	Progressive Corporat...	190.00 USD	2024-11-15	Put

GlobeNewswire 1:30 PM Plato Gold Welcomes Mr. Ernie J. Marcotte to the Board of Directors

GlobeNewswire 1:00 PM Medicare Issues Final Coverage Determination for kidneyintelX.dkd

GlobeNewswire 1:58 AM Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$1...

GlobeNewswire 06-13 Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Progr...

GlobeNewswire 06-12 Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo...

GlobeNewswire 06-12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...

GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

GlobeNewswire 06-11 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...

GlobeNewswire 06-11 FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclero...

GlobeNewswire 06-10 LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...

GlobeNewswire 06-10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...

TeleTrader 06-09 EP updated results, EPP with 189 seats

TeleTrader 06-09 EPP's Weber claims party victory in EP election

GlobeNewswire 06-07 TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire 06-07 Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...

GlobeNewswire 06-06 Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple...

GlobeNewswire 06-06 4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...

GlobeNewswire 06-05 The Alignment Studio Physiotherapy Melbourne Celebrates Receiving Only 5-Star Reviews Since Opening

GlobeNewswire 06-05 MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...

GlobeNewswire 06-05 Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...

GlobeNewswire 06-04 Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intrana...

GlobeNewswire 06-04 Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda®...

GlobeNewswire 06-03 Opthea To Present at Clinical Trials at the Summit Meeting

GlobeNewswire 06-03 TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire 06-03 MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Pati...

JP Morgan Put 190 PGR 15.11.2024/ DE000JK2LK55 /

If you wish to receive reply to your feedback, please provide your email address.